The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

This morning, at the annual Education & Training Awards breakfast, the NYC Building & Construction Industry Safety Fund ...

Twenty years ago, in 2004, Congress passed the Project BioShield Act, which established the Biomedical Advanced Research and ...

At the end of last year, the Mobile County Health Department’s (MCHD) Overdose Prevention Program worked with LTS Health on a project to supply four healthcare ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Shares of Vodafone Idea, SAIL, IRCTC, Tata Investment and Ircon will be in focus as the companies will announce their third ...

Community collaboration, harm reduction models and policy changes can ease the burden on EMS workers and improve patient outcomes ...